Literature DB >> 15964764

Thimerosal-induced cytosolic Ca2+ elevation and subsequent cell death in human osteosarcoma cells.

Hong-Tai Chang1, Chung-Shin Liu, Chiang-Ting Chou, Ching-Hong Hsieh, Chih-Hung Chang, Wei-Chuan Chen, Shiuh-Inn Liu, Shu-Shong Hsu, Jin-Shyr Chen, Bang-Ping Jiann, Chung-Ren Jan.   

Abstract

The effect of the oxidizing agent thimerosal on cytosolic free Ca(2+) concentration ([Ca(2+)]i) and proliferation has not been explored in human osteoblast-like cells. This study examined whether thimerosal alters Ca(2+) levels and causes cell death in MG63 human osteosarcoma cells. [Ca(2+)]i and cell death were measured using the fluorescent dyes fura-2 and WST-1, respectively. Thimerosal at concentrations above 5 microM increased [Ca(2+)]i in a concentration-dependent manner. The Ca(2+) signal was reduced by 80% by removing extracellular Ca(2+). The thimerosal-induced Ca(2+) influx was sensitive to blockade of La(3+), and dithiothreitol (50 microM) but was insensitive to nickel and several L-type Ca(2+) channel blockers. After pretreatment with 1 microM thapsigargin (an endoplasmic reticulum Ca(2+) pump inhibitor), thimerosal failed to induce [Ca(2+)]i rises. Inhibition of phospholipase C with 2 microM U73122 did not change thimerosal-induced [Ca(2+)]i rises. At concentrations of 5, 10 and 20 microM thimerosal killed 33, 55 and 100% cells, respectively. The cytotoxic effect of 5 microM thimerosal was reversed by 54% by prechelating cytosolic Ca(2+) with BAPTA. Collectively, in MG63 cells, thimerosal induced a [Ca(2+)]i rise by causing Ca(2+) release from endoplasmic reticulum stores and Ca(2+) influx from extracellular space. Furthermore, thimerosal can cause Ca(2+)-related cytotoxicity in a concentration-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15964764     DOI: 10.1016/j.phrs.2005.05.006

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  1 in total

1.  MBOAT7-driven phosphatidylinositol remodeling promotes the progression of clear cell renal carcinoma.

Authors:  Chase K A Neumann; Daniel J Silver; Varadharajan Venkateshwari; Renliang Zhang; C Alicia Traughber; Christopher Przybycin; Defne Bayik; Jonathan D Smith; Justin D Lathia; Brian I Rini; J Mark Brown
Journal:  Mol Metab       Date:  2020-02-03       Impact factor: 7.422

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.